Saudi FDA Approves Qalsody for ALS, Pioneering New Hope for Rare Disease Patients
Riyadh – In a landmark decision for rare disease treatment in Saudi Arabia, the Saudi Food and Drug Authority (SFDA)
Read More
Factual Version of a Story
neurofilament reduction